Cargando…
In-field and abscopal response after short-course radiation therapy in patients with metastatic Merkel cell carcinoma progressing on PD-1 checkpoint blockade: a case series
BACKGROUND: Patients with metastatic Merkel cell carcinoma (mMCC) who experience disease progression on immunotherapy have limited additional standard options. Given evidence of synergism between radiation therapy (RT) and immunotherapy, two patients progressing on PD-1 inhibition were referred for...
Autores principales: | Xu, Melody J., Wu, Susan, Daud, Adil I., Yu, Siegrid S., Yom, Sue S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5977737/ https://www.ncbi.nlm.nih.gov/pubmed/29848371 http://dx.doi.org/10.1186/s40425-018-0352-8 |
Ejemplares similares
-
Should Sentinel Lymph Node Biopsy Status Guide Adjuvant Radiation Therapy in Patients With Merkel Cell Carcinoma?
por: Ahmad, Tessnim R., et al.
Publicado: (2021) -
Radiation, Immune Checkpoint Blockade and the Abscopal Effect: A Critical Review on Timing, Dose and Fractionation
por: Buchwald, Zachary S., et al.
Publicado: (2018) -
Radiotherapy-Mediated Immunomodulation and Anti-Tumor Abscopal Effect Combining Immune Checkpoint Blockade
por: Zhao, Xinrui, et al.
Publicado: (2020) -
Immune blockade inhibitors and the radiation abscopal effect in gastrointestinal cancers
por: Voutsadakis, Ioannis A
Publicado: (2018) -
The Abscopal Effect in the Era of Checkpoint Inhibitors
por: Kodet, Ondřej, et al.
Publicado: (2021)